Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics

被引：0
|
作者：
Sundaram, G. [1 ,2 ]
Lim, C. K. [1 ]
Brew, B. J. [2 ]
Guillemin, G. J. [1 ,2 ]
机构：
[1] Univ New S Wales, Dept Pharmacol & Physiol, Sch Med Sci, Sydney, NSW 2052, Australia
[2] St Vincents Hosp, St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [21] Dysregulation of the Kynurenine Pathway in Relapsing Remitting Multiple Sclerosis and Its Correlations With Progressive Neurodegeneration
    Pires, Ananda Staats
    Krishnamurthy, Shivani
    Sharma, Samridhi
    Chow, Sharron
    Klistorner, Samuel
    Guillemin, Gilles J.
    Klistorner, Alexander
    You, Yuyi
    Heng, Benjamin
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2025, 12 (02):
  • [22] IFN-β1b induces kynurenine pathway metabolism in human macrophages:: Potential implications for multiple sclerosis treatment
    Guillemin, GJ
    Kerr, SJ
    Pemberton, LA
    Smith, DG
    Smythe, GA
    Armati, PJ
    Brew, BJ
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (12): : 1097 - 1101
  • [23] Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions
    Jovanovic, Filip
    Jovanovic, Visnja
    Knezevic, Nebojsa Nick
    CELLS, 2023, 12 (08)
  • [24] Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
    Dounay, Amy B.
    Tuttle, Jamison B.
    Verhoestt, Patrick R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (22) : 8762 - 8782
  • [25] Therapeutics for Multiple Sclerosis Symptoms
    Ben-Zacharia, Aliza Bitton
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 176 - 191
  • [26] Multiple Sclerosis Clinic and Therapeutics
    Robert, Typhaine
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (573): : 8 - 8
  • [27] Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
    Phillips, Robert S.
    Iradukunda, Emma Carine
    Hughes, Tamera
    Bowen, J. Phillip
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2019, 6
  • [28] Multiple Sclerosis: Pathogenesis and Therapeutics
    Katsara, Maria
    Apostolopoulos, Vasso
    MEDICINAL CHEMISTRY, 2018, 14 (02) : 104 - 105
  • [29] THERAPEUTICS OF MULTIPLE-SCLEROSIS
    NOSEWORTHY, JH
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (01) : 49 - 61
  • [30] Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
    Rajda, Cecilia
    Galla, Zsolt
    Polyak, Helga
    Maroti, Zoltan
    Babarczy, Kristof
    Pukoli, Daniel
    Vecsei, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
12345